Related Experiment Video

Updated: Mar 3, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

20.8K

Emerging strategies to treat the brain, behind its barrier

Wheaton T Little1, Ceri H Davies1

  • 1Takeda Pharmaceuticals, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.

Neuropharmacology
|May 7, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K
A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

9.3K

Related Experiment Videos

Last Updated: Mar 3, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

20.8K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K
A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

9.3K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

54.1K
Overview
54.1K
Brain Imaging01:14

Brain Imaging

801
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
801
Physiological Barriers01:25

Physiological Barriers

5.5K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.5K

Articles linked to this work by shared authors, journal, and citation graph.

Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.

Neurochemical research·2023

Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.

Proceedings of the National Academy of Sciences of the United States of America·2022

Strategies to Address Challenges in Neuroscience Drug Discovery and Development.

The international journal of neuropsychopharmacology·2019

The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction.

Brain : a journal of neurology·2019

Scalable Measurements of Intrinsic Excitability in Human iPS Cell-Derived Excitatory Neurons Using All-Optical Electrophysiology.

Neurochemical research·2019

Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.

Cell death & disease·2018

BLA astrocytes are associated with withdrawal somatic signs during high-dose naloxone-precipitated morphine withdrawal revealed by 3D-AI behavioral analysis.

Neuropharmacology·2026

Cocaine-Induced interindividual variability in female rats: From behavior to gene expression.

Neuropharmacology·2026

Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/δ-opioid receptor pathway.

Neuropharmacology·2026

Nitrogen Gas-Derived Cold Atmospheric Plasma Suppresses Pruritus Through Modulation of Peripheral Sensory Neurons and Keratinocytes.

Neuropharmacology·2026

Study on the role and mechanism of P2X4 receptor in allergic contact dermatitis in mice.

Neuropharmacology·2026

Intraperitoneal administration of adenosine A2A receptor antagonist reduces neuroinflammatory and antioxidant responses in GM2 gangliosidosis mouse model.

Neuropharmacology·2026

[Current Status and Challenges in the Regulation of Weight Management Medical Devices].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026

Amenamevir Transfer into Breast Milk in Patients with Herpes Simplex Virus Infection: A Brief Report of a Prospective Multicenter Study.

The Journal of dermatology·2026

Performance of large language models as a source of clinical information on bacteriophage therapy.

Npj viruses·2026

Mannose-decorated nanostructured lipid carriers improve the intracellular activity of antitubercular drugs against Mycobacterium tuberculosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Poly (Lipoic Acid) Nanoparticles With High Blood-Brain Barrier Permeability and Enhanced Anti-Ferroptotic Activity for Ischemic Stroke Treatment.

Small (Weinheim an der Bergstrasse, Germany)·2026

Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy.

Nature communications·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us